177Lu-DOTATATE PRRT Safety and Organ-at-Risk Dosimetry in Patients With Gastroenteropancreatic Neuroendocrine Tumors: Data From the Prospective Phase 2 LUMEN Study

医学 神经内分泌肿瘤 内科学 核医学 剂量学 肿瘤科
作者
Magdalena Mileva,Camille Van Bogaert,Gwennaëlle Marin,Rachele Danieli,Carlos Artigas,Hugo Levillain,Lieveke Ameye,Loubna Taraji,Konstantinos Stathopoulos,Zéna Wimana,Alain Hendlisz,Patrick Flamen,Ioannis Karfis
出处
期刊:Clinical Nuclear Medicine [Lippincott Williams & Wilkins]
卷期号:49 (9): 847-853 被引量:10
标识
DOI:10.1097/rlu.0000000000005330
摘要

PURPOSE: The aim of this study was to assess the association among toxicity, dosimetry of organs-at-risk, and disease progression in patients with gastroenteropancreatic neuroendocrine tumors (GEP-NETs) treated with 177 Lu-DOTATATE. PATIENTS AND METHODS: Thirty-seven patients with GEP-NETs underwent 177 Lu-DOTATATE peptide receptor radionuclide therapy (PRRT) in a single-arm, prospective, phase 2 study, where patients were followed up with blood tests, isotopic glomerular filtration rate (iGFR), and imaging examinations (CT/MRI and PET) every 6 months until disease progression. Adverse events (AEs) graded per CTCAEv4.03 and occurring during treatment were collected and followed up until resolution. Dosimetry, including biologically effective doses (BEDs) to kidneys, BED to bone marrow, and absorbed dose (AD) to spleen, was performed after each PRRT cycle. Statistical analyses explored associations among dosimetry, toxicity, and patient progression free-survival. RESULTS: The most common AEs were anemia and lymphopenia (65%), followed by thrombocytopenia and fatigue (each 51%), alopecia (46%), and nausea (41%). The most common grade ≥3 AE was lymphopenia (43%). There was no grade ≥3 nephrotoxicity. The median iGFR % decrease was 11% ( P < 0.001), at a median follow-up of 23 months. iGFR %decrease and renal BED did not correlate (Spearman ρ = -0.09). Similarly, no significant association was found between bone marrow BED or spleen AD and the grades of hematological toxicities. We observed no association between progression free-survival and either the decline of renal function or the occurrence of hematological toxicities during PRRT. CONCLUSIONS: This study confirms the safety profile of 177 Lu-DOTATATE PRRT in patients with GEP-NETs irrespective of the dosimetry of organs at risk. Kidney, bone marrow, and spleen dosimetry measures were not associated with renal or hematological toxicity.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
华仔的应助被Lily采纳,获得10
刚刚
程朗发布了新的文献求助30
刚刚
天天快乐的应助被兮尔采纳,获得10
1秒前
传奇3的应助被Man采纳,获得10
1秒前
苗条元霜完成签到,获得积分10
1秒前
Czz发布了新的文献求助10
1秒前
2秒前
2秒前
2秒前
jichao完成签到,获得积分10
2秒前
Bio发布了新的文献求助10
3秒前
小f完成签到,获得积分10
3秒前
3秒前
4秒前
亲爱的桃乐茜完成签到 ,获得积分10
4秒前
5秒前
5秒前
5秒前
5秒前
1176915210完成签到,获得积分10
6秒前
6秒前
6秒前
酷波er的应助被舒适香露采纳,获得10
6秒前
7秒前
安静葵阴发布了新的文献求助10
7秒前
Amelia完成签到 ,获得积分10
7秒前
8秒前
8秒前
gqz发布了新的文献求助10
9秒前
蘑菇菇发布了新的文献求助10
9秒前
张伟发布了新的文献求助10
9秒前
文献完成签到,获得积分10
10秒前
传奇3的应助被ghr777采纳,获得10
10秒前
su发布了新的文献求助10
11秒前
11秒前
aniannn发布了新的文献求助10
11秒前
hdy331完成签到,获得积分0
11秒前
Gloria2023发布了新的文献求助20
12秒前
12秒前
selena发布了新的文献求助10
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183241
求助须知:如何正确求助?哪些是违规求助? 9572493
关于积分的说明 21826218
捐赠科研通 7780115
什么是DOI,文献DOI怎么找? 3433982
关于科研通互助平台的介绍 2558103
邀请新用户注册赠送积分活动 2480192